池诏丞;王广义;

• 1:吉林省肿瘤医院腹二科
• 2:吉林大学第一临床医院普外科 (长春130012)
• 3:(长春130021)

摘要(Abstract)：

甲胎蛋白是一种胚胎性蛋白,长期以来主要用于原发性肝癌的诊断。本文就甲胎蛋白的免疫抑制作用、肿瘤细胞的生长调节作用及其研究进展进行综述。

关键词(KeyWords)： 甲胎蛋白;生物学作用;肿瘤

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 池诏丞;王广义;

DOI: 10.13200/j.cjb.2007.12.77.chizhch.013

参考文献(References)：

• [1]Tatarinov YS.Content of embryo-specific alpha-globulin in the blood serumof the humanfetus,newborn,and adult man in primary cancer of the liver.Vop KhimSSR,1965,11(1):20-24.
• [2]Mizejewski GJ.Immunologic prospects for mammalian alphafetoprotein.Clin Immunol Newslett,1981,2(5):37-39.
• [3]Dudich E,Semenkova L,Gorbatova E,et al.Growth-regulative activity of human alpha-Fetoproteinfor different types of tumor and normal cells.Tumor Biol,1998,19(1):30-40.
• [4]Leel JA,Gangrade BK,Kier JL,et al.Human mammary-turmor-cell pro-liferation:Primary role of platelet-derived growthfactor and possible syn-ergismwith human alpha-fetoprotein.Steroids,1991,56(5):247-251.
• [5]Li MS,Li PF,He SP,et al.Promoting molecular mechanismof alpha-fe-toprotein onthe growth of human hepatoma Bel7402line cells.World J Gastroenterol,2002,8(3):469-472.
• [6]Semenkova LN,Dudich EL,Dudich IV.1nduction of apoptosis in human hepatoma cells by alpha-fetoprotein.Tumor Biol,1997,8(5):261-273.
• [7]Mizejewski GJ.Alpha-fetoprotein binding proteins:Implications for trans-membrane passage and subcellular localization.Life Sci,1995,56(1):1-9.
• [8]Li MS,Li PF,He SP,et al.The intracellular mechanismof alpha-fetopro-tein promotingthe proliferation of NIH3T3cells.Cell Res,2002,12(2):151-156.
• [9]Lakita GC,Venkatraman M,Valentina MF,et al.Regulation of a-fetopro-tein by nuclear factor-κB protects hepatocytes fromtumor necrosis fac-tor-a cytotoxicity duringfetal liver development and hepatic oncogenesis.Cancer Res,2004,64(19):7030-7038.
• [10]Vollmer CM,Eicber FC,Bufferfield LH,et al.Alpha fetoprotein-specific genetic immunotherapyfor hepatocellular carcinoma.Cancer Res,1999,59(13):3064-3067.
• [11]Mizejewski GJ.Alpha-fetoprotein structure and function:relevance to isoforms,epitopes and conformational variants.Exp Biol Med,2001,226(5):377-408.
• [12]Gote NL,Israeli D,Alper R,et al.Induction of immune tolerance towanl honor-associated-antigen enables growth of human hepatoma in mice.Cancer,2002,97(1):52-57.
• [13]Nagao M,NakajinaaY,KanehimH,et a1.The impact ofinterferon gam-ma receptor expression on the mechanismof escape fromhost immune surveillance in hepatocellular carcinoma.Hepatology,2000,32(3):491-500.
• [14]Li MS,Ma QL,Chen Q,et a1.Alpha-fetoproteintriggers hepatoma cells escaping fromimmune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand anditsreceptor of lymphocytes andliver cancer cells.WorldJ Gastroen-terol,2005,11(17):2564-2569.
• [15]Dudich E,Semenkova L,DudichI,et al.Alpha-fetopmtein causes apop-tosisintumor cells via a pathway independent of CD95,TN,FR1and TNFR2through activation of caspase-3-like proteases.Eur J Biochem,1999,266(3):750-761.
• [16]范强,钟翠平,王国强,等.甲胎蛋白对树突状细胞免疫表型影响的体外研究.中国免疫学杂志,2000,17(4):180-181.
• [17]Soon HU,Mulhall C,Alisa A,et a1.α-fetoproteinimpairs APCfunction andinduces their apoptosis.J Immunol,2004,173(3):1772-1778.
• [18]Shi YJ,Gong JP,Liu CA,et al.Construction of a targeting adenoviral vector carrying AFPpromoterfor expressing EGFPgenein AFP-produc-ing hepatocarcinoma cell.World J Gastrcenterol,2004,10(2):186-89.
• [19]Bilbao R,Gerolami R,Bralet MP,et al.Transduction efficacy,antitu-moraleffect,and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma:the woodchuck animal model.Cancer Gene Ther,2000,7(5):657-662.
• [20]Antonio SC,Eric B,Sylvie D,et a1.Inhibitation of rat hepatocellular carcinomatumor growthafter multipleinfuseionsrecombinant Ad.AFPtk followed by ganciclovir treatment.J Hepatol,2002,37(2):222-230.
• [21]Jaesang K,Boyong L,Jinseok K,et a1.Antitumoral effects recombinant adenovirus YKL-1001,conditionallyreplicatingin a-Fetoprotein-preduc-ing humanliver cancer cells.Cancer Lett,2002,180(1):23-32.
• [22]Butterfield LH.Immunotherapeutic strategies for hepatocellular carcino-ma.Gastroenterology,2004,127(5Suppl1):s232-s241.
• [23]Vollmer CM,Eilber FC,Butterfield LH,et al.Alpha-fetoprotein-specific genetic immuno-therapy for hepatocellular carcinoma.Cancer Res,1999,59(13):3064-3067.
• [24]Gonzalez-Carmona MA,Marten A,Hoffmann P,et al.Patient-derived dendritic cells trans-duced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-inducedlymphocytes induce a specific and strong immune response against hepato-cellular carcinoma cells.Liver Int,2006,26(3):369-379.
• [25]张兵,陈玮,董薇,等.树突状细胞吞噬PLA-AFP218-226微球后诱导细胞毒性T淋巴细胞反应.四川大学学报,2006,37(3):378-380.
• [26]Butterfield LH,Koh A,Ming W,et al.Generation of human T-cell re-sponses to an HLA-A2.1-restricted peptide epitope derivedfromalpha-fetoprotein.Cancer Res,1999,59(13):3134-3142.
• [27]Butterfield LH,Ribas A,Dissette VB,et al.Aphase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.Clin Cancer Res,2006,12(9):2817-2825.